Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nurpra.2020.12.021 http://scihub22266oqcxt.onion/10.1016/j.nurpra.2020.12.021 34127911!8189715!34127911     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34127911&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Nurse+Pract 2021 ; 17 (6): 680-686 Nephropedia Template TP {{tp|p=34127911|t=2021. Management of Diabetes During a Dual Pandemic |pdf=|usr=}}{{34127911}} gab.com Text Management of Diabetes During a Dual Pandemic JO: J Nurse Pract http://www.kidney.de/pget.php?&tw=1&pmid=34127911 #FOAvip The dual pandemics of coronavirus disease-19 (COVID-19) and diabetes among patients are associated with 2- to 3-times higher intensive care admissions and higher mortality rates. Whether sheltering at home, quarantined with a positive COVID-19 test, or hospitalized, the person living with diabetes needs special considerations for successful management. Having diabetes and being COVID-19-positive increases the risk of poor outcomes and death. Providers need to give anticipatory pharmacologic guidance to patients with diabetes during COVID-19 lockdown. Patients with diabetes need to be more observant than others and to use self-protective actions. This review (1) discusses the clinical observations of COVID-19, diabetes and underlying mechanisms, (2) describes special considerations in caring for patients with diabetes in a COVID-19 environment, and (3) reviews clinical implications for the health care provider. This review highlights current evidenced-based knowledge. Additional research regarding clinical management is warranted. Twit Text FOAVip Management of Diabetes During a Dual Pandemic ????J Nurse Pract http://www.kidney.de/pget.php?&tw=1&pmid=34127911 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34127911 #FOAvip English Wikipedia <ref>{{Cite pmid|34127911}}</ref> Management of Diabetes During a Dual Pandemic #MMPMID34127911 Appel SJ; Wadas TM; Andrabi MS J Nurse Pract 2021[Jun]; 17 (6): 680-686 PMID34127911show ga The dual pandemics of coronavirus disease-19 (COVID-19) and diabetes among patients are associated with 2- to 3-times higher intensive care admissions and higher mortality rates. Whether sheltering at home, quarantined with a positive COVID-19 test, or hospitalized, the person living with diabetes needs special considerations for successful management. Having diabetes and being COVID-19-positive increases the risk of poor outcomes and death. Providers need to give anticipatory pharmacologic guidance to patients with diabetes during COVID-19 lockdown. Patients with diabetes need to be more observant than others and to use self-protective actions. This review (1) discusses the clinical observations of COVID-19, diabetes and underlying mechanisms, (2) describes special considerations in caring for patients with diabetes in a COVID-19 environment, and (3) reviews clinical implications for the health care provider. This review highlights current evidenced-based knowledge. Additional research regarding clinical management is warranted. ?Management of Diabetes During a Dual Pandemic (epmc).pdf DeepDyve Pubget Overpricing